West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum
West Pharmaceutical Services, Inc. (NYSE: WST ) reported better than expected second quarter 2026 earnings. The injectable solutions company reported adjusted earnings of $2.37 per share, beating the consensus of $2.08. Net sales of $872.3 million increased 13.8% year over year, with organic growth of 12.7%, beating th